The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.

Sci Rep · 2020 · PMC7746742 · PMID 33335263

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Because the chemotherapy regimen was more effective than anticipated, this trend did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.